search
Back to results

Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever

Primary Purpose

Fever

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Acetaminophen
Ibuprofen
Sponsored by
Penn State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fever focused on measuring fever treatment, children

Eligibility Criteria

6 Months - 7 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Age 6 months - 7 years of age at time of the fever. Initial temperature of 38.0C (100.4F) or more. Ability to cooperate with serial temporal artery temperature measurements. Ability to take medications by mouth. Willingness of the child's guardian/sponsor to give informed consent Exclusion Criteria: Patients who have received acetaminophen within 6 hours of presentation, or ibuprofen, aspirin, or other non-steroidal anti-inflammatory medications within 8 hours of presentation. Patients >=3 years of age that have received narcotics in the previous 24 hours. Children with weight >60 kg. Treatment of children with weights >60 kg will result in greater than recommended adult doses of the medications. History of adverse reaction to any study medication ingredient. History of diabetes mellitis, renal dysfunction, hepatic dysfunction, or thrombocytopenia. Presence of moderate or severe dehydration. Inclusion in the trial on 3 previous occasions Medical judgment that the severity of the underlying illness prohibits inclusion.

Sites / Locations

  • Penn State Milton S. Hershey Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Experimental

Arm Label

A

B

C

Arm Description

At time 0 child is given an appropriate dose of Ibuprofen (10mg/kg)

At time 0 child is given an appropriate dose of Ibuprofen (10mg/kg) and an appropriate dose of Acetaminophen (15 mg/kg)

At time 0 child is given an appropriate dose of Ibuprofen (10mg/kg) and at time 3 hours is given an appropriate dose of Acetaminophen (15 mg/kg)

Outcomes

Primary Outcome Measures

Child Temperature (Degrees C)Over 6 Hours
Temperature was measured hourly using a temporal thermometer to monitor the child's temperature in degrees C. Temperature of 38 degrees C or higher was considered febrile.

Secondary Outcome Measures

Full Information

First Posted
December 16, 2005
Last Updated
May 8, 2012
Sponsor
Penn State University
Collaborators
Children Youth and Family Consortium
search

1. Study Identification

Unique Protocol Identification Number
NCT00267293
Brief Title
Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever
Official Title
Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever
Study Type
Interventional

2. Study Status

Record Verification Date
May 2012
Overall Recruitment Status
Completed
Study Start Date
January 2006 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
June 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Penn State University
Collaborators
Children Youth and Family Consortium

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both medications together is better than giving one medication alone for the treatment of fever.
Detailed Description
Despite a lack of evidence to support their fears, a majority of parents, pediatricians, and pediatric nurses believe that fever can be dangerous to a child. This "fever phobia" has caused a majority of caregivers to aggressively treat fever with antipyretics such as ibuprofen and acetaminophen, often in combination. Although there is scant data to support the use of these medications together for fever control and none using alternating regimens, it was recently reported that 50% of pediatricians and 70% of pediatricians with less than 5 years of experience advise parents to alternate acetaminophen and ibuprofen as an attempt to achieve maximal antipyresis. While a combination of aspirin (no longer used for antipyresis in children) and acetaminophen has been shown to be superior to either agent alone for fever reduction, these data cannot be extrapolated to the pairing of ibuprofen and acetaminophen. There is evidence that combinations of acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) are more effective for the treatment of pain and can reduce opioid use when compared with a single agent. Improved activity and alertness in children have been reported after antipyretic administration. It is believed that acetaminophen and ibuprofen may be safely used together because the two medications have significantly different pathways of metabolism that are not affected by each other, and have been used abroad in combination form for over a decade. Both acetaminophen and ibuprofen have been shown to be safe when given individually or together in recommended doses for short term use. There are no reports of adverse effects from combination therapy with standard doses. In addition, while it now appears that fever itself is probably a protective physiologic response, under different circumstances it has the potential to be harmful. Fever increases the metabolic rate approximately 10% for every 1 degree C rise in body temperature. The myocardial depression,orthostatic dysfunction, and increases in oxygen consumption, respiratory minute volume, and respiratory quotient that occur may not be tolerated by all patients including some children. Because of the ubiquitous nature of the problem, childhood fever, this study has the potential to immediately impact the way clinicians and parents treat children with fever. If the combination regimens are not shown to be superior, it could limit improper medication administration and overdose. If it is superior, the combination of medications may improve other symptoms associated with fever such as discomfort. Either way, it will fill the gap that exists in the evidence-based approach to the management of childhood fever and immediately impact current practice.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fever
Keywords
fever treatment, children

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Active Comparator
Arm Description
At time 0 child is given an appropriate dose of Ibuprofen (10mg/kg)
Arm Title
B
Arm Type
Experimental
Arm Description
At time 0 child is given an appropriate dose of Ibuprofen (10mg/kg) and an appropriate dose of Acetaminophen (15 mg/kg)
Arm Title
C
Arm Type
Experimental
Arm Description
At time 0 child is given an appropriate dose of Ibuprofen (10mg/kg) and at time 3 hours is given an appropriate dose of Acetaminophen (15 mg/kg)
Intervention Type
Drug
Intervention Name(s)
Acetaminophen
Intervention Description
Given for fever control 15mg/kg
Intervention Type
Drug
Intervention Name(s)
Ibuprofen
Intervention Description
Given for fever control 10 mg/kg
Primary Outcome Measure Information:
Title
Child Temperature (Degrees C)Over 6 Hours
Description
Temperature was measured hourly using a temporal thermometer to monitor the child's temperature in degrees C. Temperature of 38 degrees C or higher was considered febrile.
Time Frame
6 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 6 months - 7 years of age at time of the fever. Initial temperature of 38.0C (100.4F) or more. Ability to cooperate with serial temporal artery temperature measurements. Ability to take medications by mouth. Willingness of the child's guardian/sponsor to give informed consent Exclusion Criteria: Patients who have received acetaminophen within 6 hours of presentation, or ibuprofen, aspirin, or other non-steroidal anti-inflammatory medications within 8 hours of presentation. Patients >=3 years of age that have received narcotics in the previous 24 hours. Children with weight >60 kg. Treatment of children with weights >60 kg will result in greater than recommended adult doses of the medications. History of adverse reaction to any study medication ingredient. History of diabetes mellitis, renal dysfunction, hepatic dysfunction, or thrombocytopenia. Presence of moderate or severe dehydration. Inclusion in the trial on 3 previous occasions Medical judgment that the severity of the underlying illness prohibits inclusion.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ian M Paul, MD
Organizational Affiliation
Penn State Milton S. Hershey Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Penn State Milton S. Hershey Medical Center
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033-0850
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
21353111
Citation
Paul IM, Sturgis SA, Yang C, Engle L, Watts H, Berlin CM Jr. Efficacy of standard doses of Ibuprofen alone, alternating, and combined with acetaminophen for the treatment of febrile children. Clin Ther. 2010 Dec;32(14):2433-40. doi: 10.1016/j.clinthera.2011.01.006.
Results Reference
derived
Links:
URL
http://www.hmc.psu.edu/pedsclinicalresearch/index.htm
Description
Penn State Milton S. Hershey Children's Hospital Pediatric Clinical Research Office

Learn more about this trial

Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever

We'll reach out to this number within 24 hrs